Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Nese Celebisoy

Nese Celebisoy

Ege University Medical School, Turkey

Title: Vestibular Migraine

Biography

Biography: Nese Celebisoy

Abstract

Vertigo and headache are frequent symptoms in neurology clinics. After several studies in the field vestibular migraine (VM) has been accepted as the term defining vestibular symptoms that are casually related to migraine and International Headache Society and Barany Society have created a consensus document with diagnostic criteria for this clinical entity. The diagnosis was considered in the appendix of the new International Classification of Headache Disorders (ICHD)-3 beta version of headache classification. VM is the most common cause for recurrent spontaneous vertigo with a lifetime prevalence of 1%, and a one-year prevalence of 0.9% in the general population. It can occur in any period of life. Women are affected more frequently than men with a gender ratio between1.5 and 5. Patients report spontaneous or positional vertigo attacks as well as imbalance. The duration of attacks generally vary from minutes to a few days. Auditory symptoms, including hearing loss, tinnitus and aural pressure have been reported in up to 38% of the patients. However, hearing loss is usually mild and transient. During an attack and in-between attacks the neuro-otological examination is generally normal. Mild central deficits such as persistent positional nystagmus or peripheral deficits such as unilateral caloric hypoexcitability have been reported. The diagnosis mainly depends on history as no abnormalities specific for vestibular migraine can be found by vestibular testing. Therapeutic studies on VM are few and treatment options are mainly based on migraine guidelines.